{
    "paper_id": "PMC7195078",
    "metadata": {
        "title": "Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis",
        "authors": [
            {
                "first": "Erkan",
                "middle": [],
                "last": "Cure",
                "suffix": "",
                "email": "erkancure@yahoo.com",
                "affiliation": {}
            },
            {
                "first": "Medine",
                "middle": [],
                "last": "Cumhur Cure",
                "suffix": "",
                "email": "medinecure@yahoo.com",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "We declare that there is no conflict of interest.",
            "cite_spans": [],
            "section": "Declaration of competing interest",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Comment on \u201cOrgan-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19\u201d",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J\u00a0Med Virol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25848"
                ]
            }
        },
        "BIBREF1": {
            "title": "Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers",
            "authors": [
                {
                    "first": "C.C.J.",
                    "middle": [],
                    "last": "Dekkers",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Petrykiv",
                    "suffix": ""
                },
                {
                    "first": "G.D.",
                    "middle": [],
                    "last": "Laverman",
                    "suffix": ""
                },
                {
                    "first": "D.Z.",
                    "middle": [],
                    "last": "Cherney",
                    "suffix": ""
                },
                {
                    "first": "R.T.",
                    "middle": [],
                    "last": "Gansevoort",
                    "suffix": ""
                },
                {
                    "first": "H.J.L.",
                    "middle": [],
                    "last": "Heerspink",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Diabetes Obes Metabol",
            "volume": "20",
            "issn": "",
            "pages": "1988-1993",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Effect of empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease",
            "authors": [
                {
                    "first": "B.A.",
                    "middle": [],
                    "last": "Kappel",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Lehrke",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Sch\u00fctt",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Artati",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Adamski",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Lebherz",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Circulation",
            "volume": "136",
            "issn": "",
            "pages": "969-972",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Comment on: \u201cHigh released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment\u201d",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Atherosclerosis",
            "volume": "296",
            "issn": "",
            "pages": "2-3",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "A\u00a0review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "S.P.",
                    "middle": [],
                    "last": "Rajeev",
                    "suffix": ""
                },
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Cuthbertson",
                    "suffix": ""
                },
                {
                    "first": "J.P.H.",
                    "middle": [],
                    "last": "Wilding",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Diabetes Obes Metabol",
            "volume": "21",
            "issn": "Suppl 2",
            "pages": "9-18",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Dapagliflozin attenuates Na(+)/H(+) exchanger-1 in cardiofibroblasts via AMPK activation",
            "authors": [
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Jia",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Bajaj",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Birnbaum",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Cardiovasc Drugs Ther",
            "volume": "32",
            "issn": "",
            "pages": "553-558",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "SGLT2 inhibitors as a therapeutic option for diabetic nephropathy",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Kawanami",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Matoba",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Takeda",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Nagai",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Akamine",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Yokota",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Int J Mol Sci",
            "volume": "18",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Comment on \u2018Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J\u00a0Hypertens",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1097/HJH.0000000000002481"
                ]
            }
        },
        "BIBREF8": {
            "title": "Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab Syndr",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.dsx.2020.04.019"
                ]
            }
        },
        "BIBREF9": {
            "title": "Diabetes is a risk factor for the progression and prognosis of COVID-19",
            "authors": [
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab Res Rev",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/dmrr.3319"
                ]
            }
        },
        "BIBREF10": {
            "title": "Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase",
            "authors": [
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Vickers",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Hales",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Kaushik",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Dick",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Gavin",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J\u00a0Biol Chem",
            "volume": "277",
            "issn": "",
            "pages": "14838-14843",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.26434/chemrxiv.11938173.v7"
                ]
            }
        },
        "BIBREF12": {
            "title": "Comment on \u2019Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nephron",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1159/000507786"
                ]
            }
        },
        "BIBREF13": {
            "title": "Comment: sodium-glucose cotransporters as potential therapeutic targets in patients with type 1 diabetes mellitus: an update on phase 3 clinical trial data",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ann Pharmacother",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1177/1060028020910204"
                ]
            }
        },
        "BIBREF14": {
            "title": "Comment on \u201cSodium-glucose Co-transporter 2 inhibitors and heart failure",
            "authors": [
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Cardiol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.amjcard.2020.03.001"
                ]
            }
        },
        "BIBREF15": {
            "title": "Potential role of NHE1 (sodium-hydrogen exchanger 1) in the cellular dysfunction of lactic acidosis: implications for treatment",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Kraut",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am J Kidney Dis",
            "volume": "57",
            "issn": "",
            "pages": "781-787",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Kimmoun",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Novy",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Auchet",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Ducrocq",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Levy",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Crit Care",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Activation and inhibition of sodium-hydrogen exchanger is a mechanism that links the pathophysiology and treatment of diabetes mellitus with that of heart failure",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Packer",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Circulation",
            "volume": "136",
            "issn": "",
            "pages": "1548-1559",
            "other_ids": {
                "DOI": []
            }
        }
    }
}